BMRRX
Price
$35.19
Change
+$0.31 (+0.89%)
Updated
Jul 25 closing price
Net Assets
8.25B
PMAQX
Price
$48.54
Change
+$0.35 (+0.73%)
Updated
Jul 25 closing price
Net Assets
33.03B
Interact to see
Advertisement

BMRRX vs PMAQX

Header iconBMRRX vs PMAQX Comparison
Open Charts BMRRX vs PMAQXBanner chart's image
BlackRock Mid-Cap Growth Equity R
Price$35.19
Change+$0.31 (+0.89%)
VolumeN/A
Net Assets8.25B
Principal MidCap R6
Price$48.54
Change+$0.35 (+0.73%)
VolumeN/A
Net Assets33.03B
BMRRX vs PMAQX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BMRRX vs. PMAQX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRRX is a Buy and PMAQX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 33B vs. BMRRX (8.25B). PMAQX pays higher dividends than BMRRX: PMAQX (0.19) vs BMRRX (0.00). BMRRX was incepted earlier than PMAQX: BMRRX (19 years) vs PMAQX (9 years). BMRRX (1.41) is less costly to investors than PMAQX (0.59). BMRRX is a more actively managed with annual turnover of: 48.00 vs. PMAQX (10.50). PMAQX has a lower initial minimum investment than BMRRX: PMAQX (0) vs BMRRX (100). PMAQX annual gain was more profitable for investors over the last year : 13.16 vs. BMRRX (10.52). PMAQX return over 5 years is better than : 57.67 vs. BMRRX (19.33).
BMRRXPMAQXBMRRX / PMAQX
Total Expense Ratio1.300.59220%
Annual Report Gross Expense Ratio1.410.59239%
Fund Existence19 years9 years-
Gain YTD-1.7747.977-22%
Front LoadN/AN/A-
Min. Initial Investment1000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.25B33B25%
Annual Yield % from dividends0.000.19-
Returns for 1 year10.5213.1680%
Returns for 3 years30.2549.7661%
Returns for 5 years19.3357.6734%
Returns for 10 years118.00N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHSCP27.720.17
+0.62%
CHS
NLOP33.420.19
+0.57%
Net Lease Office Properties
CLDX23.350.13
+0.56%
Celldex Therapeutics
MUR26.13-0.20
-0.76%
Murphy Oil Corp
IPSC0.63-0.03
-5.17%
Century Therapeutics